SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-007494
Filing Date
2021-01-13
Accepted
2021-01-12 20:53:29
Documents
7
Period of Report
2021-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848409d8k.htm 8-K 53769
2 EX-3.1 d848409dex31.htm EX-3.1 107126
3 EX-4.3 d848409dex43.htm EX-4.3 106987
4 EX-4.4 d848409dex44.htm EX-4.4 90843
5 EX-10.1 d848409dex101.htm EX-10.1 18648
6 EX-99.1 d848409dex991.htm EX-99.1 8910
7 GRAPHIC g848409dsp56.jpg GRAPHIC 5788
  Complete submission text file 0001193125-21-007494.txt   395904
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 21524753
SIC: 2834 Pharmaceutical Preparations